Search Results - "LOWSKY, R"

Chimerism, Graft Survival, and Withdrawal of Immunosuppressive Drugs in HLA Matched and Mismatched Patients After Living Donor Kidney and Hematopoietic Cell Transplantation by Scandling, J. D., Busque, S., Shizuru, J. A., Lowsky, R., Hoppe, R., Dejbakhsh‐Jones, S., Jensen, K., Shori, A., Strober, J. A., Lavori, P., Turnbull, B. B., Engleman, E. G., Strober, S.

“…Thirty‐eight HLA matched and mismatched patients given combined living donor kidney and enriched CD34+ hematopoietic cell transplants were enrolled in…”
Get full text

Tolerance and Withdrawal of Immunosuppressive Drugs in Patients Given Kidney and Hematopoietic Cell Transplants by Scandling, J. D., Busque, S., Dejbakhsh‐Jones, S., Benike, C., Sarwal, M., Millan, M. T., Shizuru, J. A., Lowsky, R., Engleman, E. G., Strober, S.

“…Sixteen patients conditioned with total lymphoid irradiation (TLI) and antithymocyte globulin (ATG) were given kidney transplants and an injection of CD34+…”
Get full text

Risks and benefits of sex-mismatched hematopoietic cell transplantation differ according to conditioning strategy by Nakasone, Hideki, Remberger, Mats, Tian, Lu, Brodin, Petter, Sahaf, Bita, Wu, Fang, Mattsson, Jonas, Lowsky, Robert, Negrin, Robert, Miklos, David B, Meyer, Everett

“…Sex-mismatched hematopoietic cell transplantation is linked to increased graft-versus-host disease and mortality in myeloablative conditioning. Here we…”
Get full text

Outcomes of adults with lymphoma treated with nonmyeloablative TLI-ATG and radiation boost to high risk or residual disease before allogeneic hematopoietic cell transplant by Dworkin, M. L., Jiang, A. L., Von Eyben, R., Spinner, M. A., Advani, R. H., Lowsky, R., Hiniker, S. M., Hoppe, R. T.

“…We evaluated the impact on survival of antithymocyte globulin conditioning (TLI-ATG) with radiation (RT) boost to high risk or residual disease before…”
Get full text

Sirolimus and mycophenolate mofetil as GVHD prophylaxis in myeloablative, matched-related donor hematopoietic cell transplantation by Johnston, L, Florek, M, Armstrong, R, McCune, J S, Arai, S, Brown, J, Laport, G, Lowsky, R, Miklos, D, Shizuru, J, Sheehan, K, Lavori, P, Negrin, R

“…We investigated sirolimus and mycophenolate mofetil (MMF) as GVHD prophylaxis in patients with advanced hematological malignancies receiving myeloablative…”
Get full text

Allogeneic hematopoietic cell transplantation after failed autologous transplant for lymphoma using TLI and anti-thymocyte globulin conditioning by Rezvani, A R, Kanate, A S, Efron, B, Chhabra, S, Kohrt, H E, Shizuru, J A, Laport, G G, Miklos, D B, Benjamin, J E, Johnston, L J, Arai, S, Weng, W-K, Negrin, R S, Strober, S, Lowsky, R

“…We describe 47 patients with lymphoma and failed prior autologous hematopoietic cell transplantation (HCT) who received TLI-ATG (anti-thymocyte globulin)…”
Get full text

A Cost Analysis of Tolerance Induction for Two‐Haplotype Match Kidney Transplant Recipients by Erickson, K. F., Winkelmayer, W. C., Busque, S., Lowsky, R., Scandling, J. D., Strober, S.

Get full text

Rhabdomyolysis after concomitant use of cyclosporine and simvastatin in a patient transplanted for multiple myeloma by Tong, J, Laport, G, Lowsky, R

Get full text

RIZ1 repression is associated with insulin-like growth factor-1 signaling activation in chronic myeloid leukemia cell lines by PASTURAL, E, TAKAHASHI, N, DONG, W.-F, BAINBRIDGE, M, HULL, A, PEARSON, D, HUANG, S, LOWSKY, R, DECOTEAU, J. F, GEYER, C. R

“…RIZ1 is a histone methyltransferase whose expression and activity are reduced in many cancers. In chronic myelogenous leukemia (CML), blastic transformation is…”
Get full text

Allogeneic hematopoietic cell transplant for normal karyotype AML: indirect evidence of selection for adverse molecular profile by Percival, M-E M, Medeiros, B C, Tian, L, Robeson, S, Laport, G G, Johnston, L J, Shizuru, J A, Miklos, D B, Arai, S, Weng, W-K, Negrin, R S, Lowsky, R

Get full text

Tandem chemo-mobilization followed by high-dose melphalan and carmustine with single autologous hematopoietic cell transplantation for multiple myeloma by Chen, A I, Negrin, R S, McMillan, A, Shizuru, J A, Johnston, L J, Lowsky, R, Miklos, D B, Arai, S, Weng, W-K, Laport, G G, Stockerl-Goldstein, K

“…Single autologous hematopoietic cell transplant (AHCT) with high-dose melphalan prolongs survival in patients with multiple myeloma but is not curative. We…”
Get full text

Long-term outcomes in patients with high-risk myeloid malignancies following matched related donor hematopoietic cell transplantation with myeloablative conditioning of BU, etoposide and CY by Naik, S, Wong, R, Arai, S, Brown, J, Laport, G, Lowsky, R, Miklos, D, Shizuru, J, Blume, K, Negrin, R, Johnston, L

“…Patients with high-risk or advanced myeloid malignancies have limited effective treatment options. These include high-dose therapy followed by allogeneic…”
Get full text

European LeukemiaNet classification intermediate risk-1 cohort is associated with poor outcomes in adults with acute myeloid leukemia undergoing allogeneic hematopoietic cell transplantation by Medeiros, B C, Tian, L, Robenson, S, Laport, G G, Johnston, L J, Shizuru, J A, Miklos, D B, Arai, S, Benjamin, J E, Weng, W-K, Negrin, R S, Lowsky, R

Get full text

Long-term follow-up of patients with diffuse large B-cell non-Hodgkin's lymphoma receiving purged autografts after induction failure by Benjamin, J E, Chen, G L, Cao, T M, Cao, P D, Wong, R M, Sheehan, K, Shizuru, J A, Johnston, L J, Negrin, R S, Lowsky, R, Laport, G G

“…Patients with diffuse large B-cell lymphoma (DLBCL) who do not achieve a complete response to front-line combination chemotherapy are often offered high-dose…”
Get full text

Secondary malignancies after bone marrow transplantation in adults by Lowsky, R, Lipton, J, Fyles, G, Minden, M, Meharchand, J, Tejpar, I, Atkins, H, Sutcliffe, S, Messner, H

“…The records of 557 consecutive adult recipients of allogeneic-related and -unrelated and syngeneic bone marrow transplants (BMTs) were reviewed to determine…”
Get more information

Outcomes Of Adult Patients With Lymphoma Treated With Nonmyeloablative Total Lymphoid Irradiation For Stem Cell Transplant (SCT) Conditioning With A Boost To High Risk Or Gross Disease by Dworkin, M.L., Hiniker, S.M., Von Eyben, R., Spinner, M.A., Advani, R.H., Lowsky, R., Hoppe, R.T.

Get full text

Immunomagnetic Selection of CD8+ Memory Cells for Therapeutic Applications by Armstrong, R, Lowsky, R, Strober, S, Sheehan, K

Get full text

Familial visceral myopathy associated with a mitochondrial myopathy by Lowsky, R, Davidson, G, Wolman, S, Jeejeebhoy, K N, Hegele, R A

“…A 27 year old man with intestinal pseudo-obstruction who developed parenteral nutrition induced hyperlipidaemia and who also had ophthalmoplegia and an…”
Get full text

DATA-DRIVEN STRATEGY FOR OPTIMIZING CRYOPRESERVED PRODUCT INVENTORY MANAGEMENT by Patel, R., Pham, T., Love, C., Beltran, J., Abello, G., Lim, L., Musa, E., Nderitu, A. Gichane, Pon, R., Bove, R., Ho, J., Monterola, G., Tadiar, H., Reddy, P., Phomsouvanh, B., Lepori-Bui, N., Diaz, N., McLeod, M., Lowsky, R., McIntyre, C.

“…- This project addresses the challenge of managing excess product inventory to optimize resource utilization, reduce costs of holding excess products, and…”
Get full text

Major ABO Mismatch Increases Red Blood Cell Transfusion Requirements After Allogeneic Hematopoietic Cell Transplantation Using Total Lymphoid Irradiation and Anti-Thymoglobulin Conditioning by Alimoghaddam, K, Weiss, S, Logan, A, Lowsky, R, Fontaine, M, Miklos, D

Get full text